Diagnosis and treatment of the hemolytic uremic syndrome disease spectrum in developing regions

Seminars in Thrombosis and Hemostasis

Volumn 40, Issue 4, 2014, Pages 478-486

  Hofer, Johannes ^a   Giner, Thomas ^a   Safouh, Hesham ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

complement screening; developing countries; hemolytic uremic syndrome; rare disease

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ANTIBIOTIC AGENT; COMPLEMENT FACTOR H; ECULIZUMAB; METALLOPROTEINASE; SHIGA TOXIN; THROMBOSPONDIN 1; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; COMPLEMENT;

ACUTE KIDNEY FAILURE; ARTICLE; DEVELOPING COUNTRY; DIAGNOSTIC ERROR; DIARRHEA; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMOLYTIC UREMIC SYNDROME; HUMAN; INCOME; INTENSIVE CARE UNIT; INTERNATIONAL COOPERATION; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE; SCREENING; THROMBOTIC THROMBOCYTOPENIC PURPURA; AFRICA; ASIA; CHEMISTRY; HEMOLYTIC-UREMIC SYNDROME; IMMUNOLOGY; SOUTH AMERICA; TREATMENT OUTCOME;

AFRICA; ASIA; COMPLEMENT SYSTEM PROTEINS; DEVELOPING COUNTRIES; ENTEROHEMORRHAGIC ESCHERICHIA COLI; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INTERNATIONAL COOPERATION; SHIGA TOXIN; SOUTH AMERICA; TREATMENT OUTCOME;

EID: 84902277089     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0034-1376154     Document Type: Article

References (72)

1. Van Weely S., Leufkens H. G. Priority medicines for Europe and the world - a public health approach to innovation. In: Kaplan W., Laing R., eds. Orphan Diseases. Geneva World Health Organization: 2004; 95 100
2. Shayman J. A. Thinking about rare kidney diseases. J Am Soc Nephrol: 2006; 17 1 15 16
3. Mark Taylor C. Enterohaemorrhagic Escherichia coli and Shigella dysenteriae type 1-induced haemolytic uraemic syndrome. Pediatr Nephrol: 2008; 23 9 1425 1431
4. Fernández-Brando R. J., Bentancor L. V., Mejías M. P., et al. Update on the treatment of endemic hemolytic uremic syndrome. Pathogenesis and treatment of the most severe systemic complication of infections by Shiga toxin-producing Escherichia coli [in Spanish]. Medicina (B Aires): 2011; 71 4 383 389
5. López E. L., Contrini M. M., Glatstein E., et al. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values. Pediatr Infect Dis J: 2012; 31 1 20 24
6. Srivastava R. N., Moudgil A., Bagga A., Vasudev A. S. Hemolytic uremic syndrome in children in northern India. Pediatr Nephrol: 1991; 5 3 284 288
7. Arora P., Kher V., Gupta A., et al. Pattern of acute renal failure at a referral hospital. Indian Pediatr: 1994; 31 9 1047 1053
8. Lanewala A., Mubarak M., Akhter F., Aziz S., Bhatti S., Kazi J. I. Pattern of pediatric renal disease observed in native renal biopsies in Pakistan. J Nephrol: 2009; 22 6 739 746
9. Jamal A., Ramzan A. Renal and post-renal causes of acute renal failure in children. J Coll Physicians Surg Pak: 2004; 14 7 411 415
10. Safouh H. The hemolytic uremic syndrome in Egyptian children. Paper presented at: 2nd International Conference on HUS-MPGN-PNH; June 13-June 15: 2010;; Innsbruck, Austria
11. Germani Y., Soro B., Vohito M., Morel O., Morvan J. Enterohaemorrhagic Escherichia coli in Central African Republic. Lancet: 1997; 349 9066 1670
12. Shimelis D., Tadesse Y. Clinical profile of acute renal failure in children admitted to the department of pediatrics, Tikur Anbessa Hospital. Ethiop Med J: 2004; 42 1 17 22
13. Bentancor A. B., Ameal L. A., Calviño M. F., Martinez M. C., Miccio L., Degregorio O. J. Risk factors for Shiga toxin-producing Escherichia coli infections in preadolescent schoolchildren in Buenos Aires, Argentina. J Infect Dev Ctries: 2012; 6 5 378 386
14. Rivero M. A., Passucci J. A., Rodriguez E. M., Signorini M. L., Tarabla H. D., Parma A. E. Factors associated with sporadic verotoxigenic Escherichia coli infection in children with diarrhea from the Central Eastern Area of Argentina. Foodborne Pathog Dis: 2011; 8 8 901 906
15. Rivero M. A., Passucci J. A., Rodríguez E. M., Parma A. E. Seasonal variation of HUS occurrence and VTEC infection in children with acute diarrhoea from Argentina. Eur J Clin Microbiol Infect Dis: 2012; 31 6 1131 1135
16. de Souza R. L., Abreu Carvalhaes J. T., Sanae Nishimura L., de Andrade M. C., Cabilio Guth B. E. Hemolytic uremic syndrome in pediatric intensive care units in São Paulo, Brazil. Open Microbiol J: 2011; 5 76 82
17. Contreras C. A., Ochoa T. J., Ruiz J., et al. Phylogenetic relationships of Shiga toxin-producing Escherichia coli isolated from Peruvian children. J Med Microbiol: 2011; 60 Pt 5 639 646
18. Zambrano O P., Delucchi B A., Cavagnaro S F., et al. Hemolytic-uremic syndrome in Chile: clinical features, evolution and prognostic factors [in Spanish]. Rev Med Chil: 2008; 136 10 1240 1246
19. Bhattacharya M., Dhingra D., Mantan M., Upare S., Sethi G. R. Acute renal failure in children in a tertiary care center. Saudi J Kidney Dis Transpl: 2013; 24 2 413 417
20. Krishnamurthy S., Narayanan P., Prabha S., et al. Clinical profile of acute kidney injury in a pediatric intensive care unit from Southern India: a prospective observational study. Indian J Crit Care Med: 2013; 17 4 207 213
21. Hari P., Singla I. K., Mantan M., Kanitkar M., Batra B., Bagga A. Chronic renal failure in children. Indian Pediatr: 2003; 40 11 1035 1042
22. Xiong Y., Wang P., Lan R., et al. A novel Escherichia coli O157:H7 clone causing a major hemolytic uremic syndrome outbreak in China. PLoS ONE: 2012; 7 4 e36144
23. Wang H., Jing H. Q., Li H. W., et al. Epidemiological study on an outbreak caused by E. coli O157:H7 in Jiangsu province [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi: 2004; 25 11 938 940
24. Al-Eisa A., Al-Hajeri M. Hemolytic uremic syndrome in Kuwaiti Arab children. Pediatr Nephrol: 2001; 16 12 1093 1098
25. Mahmoud A. M., Al-Harbi M. S., Al-Sowailem A. M., Mattoo T. K. Etiology, presentation and management of acute renal failure in Saudi children. Ann Saudi Med: 1992; 12 2 196 200
26. Elzouki A. Y., Mirza K., Mahmood A., Al-Sowailem A. M. Hemolytic uremic syndrome - clinical aspects and outcome of an outbreak: report of 28 cases. Ann Saudi Med: 1995; 15 2 113 116
27. Al-Qarawi S., Fontaine R. E., Al-Qahtani M. S. An outbreak of hemolytic uremic syndrome associated with antibiotic treatment of hospital inpatients for dysentery. Emerg Infect Dis: 1995; 1 4 138 140
28. Al Harbi N. N., Elawad M. E., Al Homrany M. A. Hemolytic-uremic syndrome in asir region. J Family Community Med: 1996; 3 1 53 57
29. Hamed R. M. The spectrum of chronic renal failure among Jordanian children. J Nephrol: 2002; 15 2 130 135
30. Olowu W. A., Adelusola K. A. Pediatric acute renal failure in southwestern Nigeria. Kidney Int: 2004; 66 4 1541 1548
31. Olotu A. I., Mithwani S., Newton C. R. Haemolytic uraemic syndrome in children admitted to a rural district hospital in Kenya. Trop Doct: 2008; 38 3 165 167
32. Oneko M., Nyathi M. N., Doehring E. Post-dysenteric hemolytic uremic syndrome in Bulawayo, Zimbabwe. Pediatr Nephrol: 2001; 16 12 1142 1145
33. Bhimma R., Rollins N. C., Coovadia H. M., Adhikari M. Post-dysenteric hemolytic uremic syndrome in children during an epidemic of Shigella dysentery in Kwazulu/Natal. Pediatr Nephrol: 1997; 11 5 560 564
34. Leban N., Aloui S., Touati D., et al. Atypical hemolytic uremic syndrome in the Tunisian population. Int Urol Nephrol: 2011; 43 2 559 564
35. Mehrazma M., Hooman N., Otukesh H. Prognostic value of renal pathological findings in children with atypical hemolytic uremic syndrome. Iran J Kidney Dis: 2011; 5 6 380 385
36. Safouh H., Riedl M., Jeller V., et al. Causes of the atypical hemolytic uremic syndrome in Egyptian children. Poster presented at: 16th Congress of the International Pediatric Nephrology Association; August 30-September 3 2013: Shanghai, China
37. Farthing M., Lindberg G., Dite P., et al. World Gastroenterology Organisation practice guideline: Acute diarrhea. 2008;; pp 1-29, Available at: http://www.worldgastroenterology.org/acute-diarrhea-in-adults.html. Accessed: May 1, 2014
38. Fischer Walker C. L., Perin J., Aryee M. J., Boschi-Pinto C., Black R. E. Diarrhea incidence in low- and middle-income countries in 1990 and 2010: a systematic review. BMC Public Health: 2012; 12 220
39. Ake J. A., Jelacic S., Ciol M., et al. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics: 2005; 115 6 e673 680
40. Burton-MacLeod J. A., Kane E. M., Beard R. S., Hadley L. A., Glass R. I., Ando T. Evaluation and comparison of two commercial enzyme-linked immunosorbent assay kits for detection of antigenically diverse human noroviruses in stool samples. J Clin Microbiol: 2004; 42 6 2587 2595
41. Rosales A., Hofer J., Zimmerhackl L. B., et al. German-Austrian HUS Study Group. Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Clin Infect Dis: 2012; 54 10 1413 1421
42. Tarr P. I., Gordon C. A., Chandler W. L. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet: 2005; 365 9464 1073 1086
43. Lapeyraque A. L., Malina M., Fremeaux-Bacchi V., et al. Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med: 2011; 364 26 2561 2563
44. Orth-Höller D., Würzner R. Role of complement in enterohemorrhagic Escherichia coli -induced hemolytic uremic syndrome. Semin Thromb Hemost: 2014; 40 4 503 507
45. Awasthi S., Agarwal G. G., Mishra V., et al. Four-country surveillance of intestinal intussusception and diarrhoea in children. J Paediatr Child Health: 2009; 45 3 82 86
46. Zhang X., McDaniel A. D., Wolf L. E., Keusch G. T., Waldor M. K., Acheson D. W. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis: 2000; 181 2 664 670
47. Safdar N., Said A., Gangnon R. E., Maki D. G. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis. JAMA: 2002; 288 8 996 1001
48. Wong C. S., Mooney J. C., Brandt J. R., et al. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin Infect Dis: 2012; 55 1 33 41
49. Bell B. P., Griffin P. M., Lozano P., Christie D. L., Kobayashi J. M., Tarr P. I. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics: 1997; 100 1 E12
50. Nelson J. M., Griffin P. M., Jones T. F., Smith K. E., Scallan E. Antimicrobial and antimotility agent use in persons with shiga toxin-producing Escherichia coli O157 infection in FoodNet Sites. Clin Infect Dis: 2011; 52 9 1130 1132
51. Osswald H., Gleiter C. Hypernatremia and kidney function [in German]. Zentralbl Chir: 1993; 118 5 267 272
52. Farquhar W. B., Morgan A. L., Zambraski E. J., Kenney W. L. Effects of acetaminophen and ibuprofen on renal function in the stressed kidney. J Appl Physiol (1985): 1999; 86 2 598 604
53. Gianviti A., Tozzi A. E., De Petris L., et al. Risk factors for poor renal prognosis in children with hemolytic uremic syndrome. Pediatr Nephrol: 2003; 18 12 1229 1235
54. Roumenina L. T., Loirat C., Dragon-Durey M. A., Halbwachs-Mecarelli L., Sautes-Fridman C., Fremeaux-Bacchi V. Alternative complement pathway assessment in patients with atypical HUS. J Immunol Methods: 2011; 365 1-2 8 26
55. Safouh H. HUS in Developing Countries: Diagnostic and Therapeutic Difficulties. Paper presented at: 3rd International Conference on HUS-MPGN-PNH; May 22-24, 2011; Innsbruck, Austria
56. Michon B., Moghrabi A., Winikoff R., et al. Complications of apheresis in children. Transfusion: 2007; 47 10 1837 1842
57. Witt V., Stegmayr B., Ptak J., et al. World apheresis registry data from 2003 to 2007, the pediatric and adolescent side of the registry. Transfus Apheresis Sci: 2008; 39 3 255 260
58. Bamgboye E. L. Barriers to a functional renal transplant program in developing countries. Ethn Dis: 2009; 19 (1, Suppl 1) S1 S56, 9
59. Rizvi S. A., Naqvi S. A., Hussain Z., et al. Renal transplantation in developing countries. Kidney Int Suppl: 2003; 83 S96 S100
60. Akoh J. A. Renal transplantation in developing countries. Saudi J Kidney Dis Transpl: 2011; 22 4 637 650
61. Legendre C. M., Licht C., Muus P., et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med: 2013; 368 23 2169 2181
62. Zuber J., Le Quintrec M., Sberro-Soussan R., Loirat C., Frémeaux-Bacchi V., Legendre C. New insights into postrenal transplant hemolytic uremic syndrome. Nat Rev Nephrol: 2011; 7 1 23 35
63. Campistol J. M., Arias M., Ariceta G., et al. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document. Nefrologia: 2013; 33 1 27 45
64. Zuber J., Fakhouri F., Roumenina L. T., Loirat C., Frémeaux-Bacchi V.; French Study Group for aHUS/C3G. Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies. Nat Rev Nephrol: 2012; 8 11 643 657
65. Westra D., Wetzels J. F., Volokhina E. B., van den Heuvel L. P., van de Kar N. C. A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome. Neth J Med: 2012; 70 3 121 129
66. United Nations, Department of Economic and Social Affairs, Population Division World Population Prospects: The 2010 Revision, Volume I (Comprehensive Tables) and II (Demographic Profiles): 2011;; Available at: http://esa.un.org/ unpd/wpp/Documentation/WPP%202010%20publications.htm. Accessed: May 1, 2014
67. Riedl M., Fakhouri F., Le Quintrec M., et al. The spectrum of complement-mediated thrombotic microangiopathies-pathogenetic insights identifying novel treatment approaches. Semin Thromb Hemost: 2014; 40 4 444 464
68. Hassenpflug W. A., Budde U., Schneppenheim S., Schneppenheim R. Inherited thrombotic thrombocytopenic purpura in children. Semin Thromb Hemost: 2014; 40 4 487 492
69. Knöbl P. Inherited and acquired thrombotic thrombocytopenic purpura (TTP) in adults. Semin Thromb Hemost: 2014; 40 4 493 502
70. Hofer J., Giner T., Józsi M. Complement factor H-antibody-associated hemolytic uremic syndrome: pathogenesis, clinical presentation, and treatment. Semin Thromb Hemost: 2014; 40 4 431 443
71. Ariceta G., Besbas N., Johnson S., et al. European Paediatric Study Group for HUS. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatr Nephrol: 2009; 24 4 687 696
72. Würzner R., Riedl M., Rosales A., Orth-Höller D. Treatment of enterohemorrhagic Escherichia coli -induced hemolytic uremic syndrome (eHUS). Semin Thromb Hemost: 2014; 40 4 508 516